
COVID – 19: ANVISA publishes resolution on requests for registration of drugs, biological products, products for in vitro diagnosis, and post-registration change of both drugs and biological products due to the international public health emergency resulting from the new Coronavirus
ANVISA published today the Resolution (RDC) No. 348/2020, providing for the requirements and extraordinary and temporary procedures for the treatment of requests for registration of drugs, biological products, products for in vitro diagnosis, and post-registration change of both drugs and biological products due to the international public health emergency resulting from the new Coronavirus. In […]